Loading clinical trials...
Loading clinical trials...
Spinal metastases indicate for an incurable course of disease. Local tumor control after palliative radiotherapy of spinal metastases (10x3 Gy, 1x8Gy) is between 61 to 81%. In 30% of patients, therapy...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Erlangen-Nürnberg Medical School
NCT05589701 · Spinal Metastases
NCT06548061 · Spinal Metastases
NCT06173401 · Spinal Metastases
NCT06244264 · Spinal Metastases, Blood Transfusion Complication, and more
NCT04863612 · Extradural Tumor, Spinal Metastases
Universitätsklinikum Erlangen
Erlangen
Universitätsklinikum Frankfurt; Strahlentherapie
Frankfurt/M.
Universitätsklinikum Regensburg, Strahlentherapie
Regensburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions